These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30453359)

  • 1. [Not Available].
    Dötsch J; Endres S
    Drug Res (Stuttg); 2018 Nov; 68(S 01):S2. PubMed ID: 30453359
    [No Abstract]   [Full Text] [Related]  

  • 2. [Not Available].
    Mentzer D
    Drug Res (Stuttg); 2018 Nov; 68(S 01):S19-S20. PubMed ID: 30453370
    [No Abstract]   [Full Text] [Related]  

  • 3. Minors and a Dawning Paradigm Shift in "Pediatric" Drug Development.
    Rose K; Tanjinatus O; Grant-Kels JM; Ettienne EB; Striano P; Neubauer D
    J Clin Pharmacol; 2021 Jun; 61(6):736-739. PubMed ID: 33368372
    [No Abstract]   [Full Text] [Related]  

  • 4. Adolescents and Drug Development: Commentary on a Dawning Paradigm Shift.
    Kearns GL; van den Anker JN
    J Clin Pharmacol; 2021 Jun; 61(6):740-743. PubMed ID: 33797778
    [No Abstract]   [Full Text] [Related]  

  • 5. Promoting Safe Early Clinical Research of Novel Drug Candidates: A European Union Regulatory Perspective.
    Ponzano S; Blake K; Bonelli M; Enzmann H;
    Clin Pharmacol Ther; 2018 Apr; 103(4):564-566. PubMed ID: 29105746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Not Available].
    Hildebrand H
    Drug Res (Stuttg); 2018 Nov; 68(S 01):S16-S17. PubMed ID: 30453368
    [No Abstract]   [Full Text] [Related]  

  • 7. European & Developing Countries Clinical Trials Partnership (EDCTP).
    Olesen OF
    Hum Vaccin Immunother; 2018 Jan; 14(1):14-16. PubMed ID: 29136388
    [No Abstract]   [Full Text] [Related]  

  • 8. Promoting Pediatric Drug Research and Labeling - Outcomes of Legislation.
    Bourgeois FT; Kesselheim AS
    N Engl J Med; 2019 Aug; 381(9):875-881. PubMed ID: 31461599
    [No Abstract]   [Full Text] [Related]  

  • 9. Use the patent system to regulate gene editing.
    Parthasarathy S
    Nature; 2018 Oct; 562(7728):486-488. PubMed ID: 30353159
    [No Abstract]   [Full Text] [Related]  

  • 10. Optimizing Pediatric Medicine Developments in the European Union Through Pragmatic Approaches.
    Rei Bolislis W; Bejeuhr G; Benzaghou F; Corriol-Rohou S; Herrero-Martinez E; Hildebrand H; Hill-Venning C; Hoogland H; Johnson C; Joos A; Vart R; Le Visage G; Kühler TC
    Clin Pharmacol Ther; 2021 Oct; 110(4):871-879. PubMed ID: 33411346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model-Informed Assessment of Anti-Infectives for Young Children in Low- and Middle-Income Countries.
    Zhao P; Arm J; Ma LF; Ward S; Hermann D; Wesche D; Hartman D; Kern S
    CPT Pharmacometrics Syst Pharmacol; 2019 Apr; 8(4):201-204. PubMed ID: 30714344
    [No Abstract]   [Full Text] [Related]  

  • 12. An Industry Perspective on the 2017 EMA Guideline on First-in-Human and Early Clinical Trials.
    DeGeorge J; Robertson S; Butler L; Derzi M; Stoch SA; Diaz D; Hartke J; Guzzie-Peck P; Mortimer-Cassen E; Bogdanffy M; Will Y; Greene N
    Clin Pharmacol Ther; 2018 Apr; 103(4):566-569. PubMed ID: 29285748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Procrustean pathways for complex generic drugs development.
    Cristofoletti R; Schmidt S; Diniz A
    Ther Deliv; 2018 Sep; 9(9):605-607. PubMed ID: 30189807
    [No Abstract]   [Full Text] [Related]  

  • 14. Tiny and Forgotten: A Call for Focused Neonatal Policy Reform.
    Bucci-Rechtweg CM; Ward RM
    Ther Innov Regul Sci; 2019 Sep; 53(5):615-617. PubMed ID: 30621453
    [No Abstract]   [Full Text] [Related]  

  • 15. New Drugs and Clinical Trials Rules-2019: What academicians need to know.
    Lahiry S; Thakur S; Chakraborty DS
    Indian J Dermatol Venereol Leprol; 2020; 86(4):445-448. PubMed ID: 32394898
    [No Abstract]   [Full Text] [Related]  

  • 16. Commentary on the EMA Reflection Paper on the use of extrapolation in the development of medicines for paediatrics.
    Ollivier C; Thomson A; Manolis E; Blake K; Karlsson KE; Knibbe CAJ; Pons G; Hemmings R
    Br J Clin Pharmacol; 2019 Apr; 85(4):659-668. PubMed ID: 30707770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European Union clinical trials directive.
    Bull Med Ethics; 2001 Jul; (169):13-24. PubMed ID: 11878337
    [No Abstract]   [Full Text] [Related]  

  • 18. Demystifying biosimilars: development, regulation and clinical use.
    Rugo HS; Rifkin RM; Declerck P; Bair AH; Morgan G
    Future Oncol; 2019 Mar; 15(7):777-790. PubMed ID: 30500264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory Considerations and Streamlined Development Programs for Antibacterial Drugs for Serious Bacterial Diseases.
    Jang SH
    Clin Pharmacol Ther; 2021 Dec; 110(6):1429-1431. PubMed ID: 33404098
    [No Abstract]   [Full Text] [Related]  

  • 20. The consequences of 'Brexit' for drug discovery and development, and the regulatory implications.
    Golding BT; Waring MJ
    Expert Opin Drug Discov; 2018 Jul; 13(7):583-585. PubMed ID: 29634365
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.